False-positive results of screening for antibodies to human immunodeficiency virus in chronic hemodialysis patients.
Eighty-three chronic hemodialysis patients were tested for human immunodeficiency virus (HIV) infection. Testing included screening enzyme immunoassay (EIA) for HIV antibodies, competitive EIA for envelope and core antibodies, EIA for HIV antigen, and lymphocyte culture. Five (6%) of the patients had positive screening EIA at low reactivity. Four of these five had antibodies to H-9 cellular antigens. Comparison of the five seropositive patients to matched controls showed no significant differences in number of lymphocytes or helper/suppressor ratio. Six months later, the five patients had negative screening EIA results using a kit with a manufacturing change approved by the Food and Drug Administration that provided improved specificity. In addition, their Western blot analysis was negative. We conclude that (1) false-positive screening EIA results are more common in chronic hemodialysis patients than other populations; (2) evaluation of chronic hemodialysis patients for HIV infection requires confirmatory tests; and (3) newer EIA screening kits appear to have improved specificity.
Arnow
P M
PM
Department of Medicine, University of Chicago, IL.
Fellner
S
S
Harrington
R
R
Leuther
M
M
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002460:Cell Line; D003429:Cross Reactions; D005189:False Positive Reactions; D005260:Female; D006678:HIV / Q000276:immunology; D015483:HIV Antibodies; D006679:HIV Seropositivity; D006801:Humans; D007124:Immunoenzyme Techniques; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012307:Risk Factors
D000914:Antibodies, Viral; D015483:HIV Antibodies